1 completed, 1 not yet recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Pyrimethamine (PYR): new trials by email Literature Review of Pyrimethamine (PYR) trials Research Report on Pyrimethamine (PYR)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combining Latency Reversing Agents to Address the HIV Reservoir Pyrimethamine (PYR), Lenalidomide, Topiramate (drug) - HIV (Human Immunodeficiency Virus), HIV -1 Infection | Phase 1 / Phase 2 | Not yet recruiting | Erasmus Medical Center | 30 | 2026-04-01 | 2026-02-03 |
| Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Trial to Determine Safety and Protective Efficacy of Sanaria PfSPZ Challenge With Concurrent Pyrimethamine Treatment That Inhibits Development of Asexual B... Chloroquine (CQ), Pyrimethamine (PYR), Sanaria PfSPZ Challenge (NF54) - Malaria | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 57 | 2015-07-21 | 2017-07-02 |
Acquired Immunodeficiency Syndrome (1) · Infections (1) · Malaria (1)
Erasmus Medical Center (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Netherlands (1) · United States (1)
Casper Rokx, MD PhD (1) · Sara A Healy, M.D. (1)